Tuesday, February 02, 2016 3:41:16 PM
Regarding "monetization being priced in". Agree, right now there is NO confidence in monetization, thus the share price languishing at a fraction of book value. The fear that IS (mostly) priced in is that company will not be able to execute its plan and will continue to draw salaries for another 4 years without being able to do anything in this sphere. Like you, I think this expectation is incorrect, thus my core position. But neither you nor I yet know whether WE are correct or whether the current view is correct. We are going on our interpretation of data and thinking the the current NON-expectation is an error based on past experience as opposed to future execution. Hopefully, we'll get a clue soon as to whether the market is mispricing this stock on the downside.
good luck. Whether or not I fully understand your explanations or not (which I certainly try to do and welcome your corrections), we both share a common core value that thinks the probabilities are good going forward.
arp
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM